D.E. Shaw & Co’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-287,398
Closed -$980K 4817
2025
Q4
$980K Sell
287,398
-157,122
-35% -$763K ﹤0.01% 3561
2025
Q3
$3.02M Sell
444,520
-775,284
-64% -$6.4M ﹤0.01% 2646
2025
Q2
$16.6M Buy
1,219,804
+643,978
+112% +$6.08M 0.01% 1151
2025
Q1
$3.13M Buy
575,826
+417,403
+263% +$2.37M ﹤0.01% 2266
2024
Q4
$784K Buy
158,423
+141,307
+826% +$741K ﹤0.01% 3355
2024
Q3
$89.7K Buy
+17,116
New +$98.7K ﹤0.01% 4260
2022
Q2
Sell
-12,776
Closed -$45K 5566
2022
Q1
$45K Sell
12,776
-88,885
-87% -$316K ﹤0.01% 5162
2021
Q4
$393K Buy
101,661
+78,839
+345% +$373K ﹤0.01% 4536
2021
Q3
$142K Buy
+22,822
New +$195K ﹤0.01% 4646

Other funds holding LFMD

D.E. Shaw & Co's LFMD Position: Q1 2026 in Review

D.E. Shaw & Co sold out of LifeMD (LFMD) in Q1 2026, closing a stake of 287,398 shares — an estimated $980K sold.

D.E. Shaw & Co first reported a position in LFMD in Q3 2021 and held it in 9 quarters. The position peaked at $16.6M in Q2 2025. 102 funds tracked by Wall St. Rank hold LFMD as of Q1 2026.

  • D.E. Shaw & Co reported no remaining LifeMD position as of Q1 2026 after selling out during the quarter.
  • D.E. Shaw & Co sold 287,398 LifeMD shares in Q1 2026, an estimated $980K.
  • D.E. Shaw & Co first reported a position in LifeMD in Q3 2021 and held it in 9 quarters.
  • D.E. Shaw & Co's LifeMD position peaked at $16.6M in Q2 2025.
  • 102 funds tracked by Wall St. Rank held LifeMD as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.